Given the excellent prognosis and availability of evidence-based treatment, patients with early-stage breast cancer are at risk of overtreatment. In this review, we summarize key opportunities to incorporate value-based decisions to optimize the delivery of high-value treatment across the breast cancer care continuum.
Keywords: Breast cancer; Cancer care continuum; De-implementation; Overtreatment; Value in health care.
Copyright © 2023 Elsevier Inc. All rights reserved.